Gagne, Joshua J. http://orcid.org/0000-0001-5428-9733
Popovic, Jennifer R.
Nguyen, Michael
Sandhu, Sukhminder K.
Greene, Patty
Izem, Rima
Jiang, Wenlei
Wang, Zhong
Zhao, Yueqin
Petrone, Andrew B.
Wagner, Anita K.
Dutcher, Sarah K.
Funding for this research was provided by:
U.S. Food and Drug Administration (HHSF223201400030I)
Article History
First Online: 17 August 2018
Compliance with Ethical Standards
:
: The Sentinel program is funded by the US Food and Drug Administration through the Department of Health and Human Services contract number HHSF223201400030I. The views expressed in this paper are those of the authors and are not intended to convey official US Food and Drug Administration policy or guidance.
: Joshua J. Gagne has received salary support from grants from Novartis Pharmaceuticals Corporation and Eli Lilly and Company to Brigham and Women’s Hospital and is a consultant to Aetion, Inc. and to Optum, Inc., all for unrelated work. Jennifer R. Popovic, Michael Nguyen, Sukhminder K. Sandhu, Patty Greene, Rima Izem, Wenlei Jiang, Zhong Wang, Yueqin Zhao, Andrew B. Petrone, Anita K. Wagner, Sarah K. Dutcher have no conflicts of interest.
: This study was conducted within the Sentinel system and represents a public health activity under the auspices of the US Food and Drug Administration. Activities conducted within Sentinel are not under the purview of institutional review boards.